Publication

FASN inhibition targets multiple drivers of NASH by reducing steatosis, inflammation and fibrosis in preclinical models

Scientific Reports 2022 12(1):15661, 2022

O’Farrell M, Duke G, Crowley R, Buckley D, Martins EB, Bhattacharya D, Friedman SL, Kemble G

Share this page

Resource Library

Related resources

Obeticholic acid improves histological, biochemical and gene expression profiles in Gubra AMLN mice with diet-induced and biopsy-confirmed NASH

Multi-omics characterization of a diet-induced obese model of non-alcoholic steatohepatitis

Metabolic, biochemical, histological, and transcriptomic effects of Firsocostat in the GAN diet-induced obese and biopsy-confirmed mouse model of NASH 

Metabolic, biochemical, histopathological, and transcriptomic effects of Seladelpar in the GAN diet-induced obese and biopsy-confirmed mouse model of NASH

For further information

Contact us

Gubra

Hørsholm Kongevej 11B
2970 Hørsholm
Denmark

+45 3152 2650